1,4-dihydropyridine has been researched along with Chronic Kidney Failure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ellerbeck, EF; Mahnken, JD; Phadnis, MA; Shireman, TI; Wetmore, JB | 1 |
Allen, AS; Chua, BS; Griffith, TF; Klassen, PS; Reddan, DN; Szczech, LA | 1 |
Bakris, GL; Greene, T; Hebert, L; Lea, J; Lipkowitz, M; Massry, S; Middleton, J; Miller, E; Rostand, SG; Smith, W | 1 |
1 trial(s) available for 1,4-dihydropyridine and Chronic Kidney Failure
Article | Year |
---|---|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Prognosis; Proteinuria; Ramipril; Risk Factors; Treatment Outcome; United States | 2005 |
2 other study(ies) available for 1,4-dihydropyridine and Chronic Kidney Failure
Article | Year |
---|---|
Relationship between calcium channel blocker class and mortality in dialysis.
Topics: Calcium Channel Blockers; Cohort Studies; Comorbidity; Dihydropyridines; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Medicaid; Medicare; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; United States | 2015 |
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Comorbidity; Diabetes Mellitus; Dihydropyridines; Drug Prescriptions; Drug Utilization; Female; Humans; Hypertension; Kidney Failure, Chronic; Logistic Models; Lung Diseases; Male; Middle Aged; Peritoneal Dialysis; Prospective Studies; Renal Dialysis | 2003 |